Original language | English |
---|---|
Pages (from-to) | 2106-2110 |
Number of pages | 5 |
Journal | Journal of Thrombosis and Haemostasis |
Volume | 16 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2018 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of Thrombosis and Haemostasis, Vol. 16, No. 10, 10.2018, p. 2106-2110.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - The predictive value of factor VIII/factor IX levels to define the severity of hemophilia
T2 - communication from the SSC of ISTH
AU - the subcommittee on factor viii, factor ix and rare coagulation disorders
AU - Mancuso, M. E.
AU - Bidlingmaier, C.
AU - Mahlangu, J. N.
AU - Carcao, M.
AU - Tosetto, A.
AU - Kurnik, Karin
AU - Blatny, Jan
AU - Castaman, Giancarlo
AU - Linari, Silvia
AU - Cid, Ana Rosa
AU - Dargaud, Yesim
AU - Grabell, Julie
AU - James, Paula
AU - Holzhauer, Suzanne
AU - Kavakli, Kaan
AU - Kenet, Gili
AU - Key, Nigel
AU - Abajas, Yasmina
AU - Ming, Lim
AU - Mingot-Castellano, Maria Eva
AU - Ozelo, Margaret
AU - Pabinger, Ingrid
AU - Santoro, Cristina
AU - Tagliaferri, Annarita
AU - Klukowska, Anna
N1 - Funding Information: A. Tosetto reports lecture honoraria from Werfen, Stago, Novo-Nordisk and Roche. M. Carcao reports grants and personal fees from Bioverativ/Sonofi, CSL-Behring, Novo Nordisk, Octapharma and Pfizer, and personal fees from Bayer, Biotest, Grifols, LFB, Roche and Shire, outside the submitted work. C. Bidlingmaier reports grants, personal fees and non-financial support from CSL Behring, Sobi, Bayer, Shir, and Biotest, grants and personal fees from Pfizer, grants and non-financial support from Novo-Nordisk, non-financial support from Roche, and grants from Intersero, outside the submitted work. M. E. Man-cuso reports personal fees from Bayer Healthcare, CSL Behring, Baxalta/Shire, Pfizer, Novo Nordisk, Octa-pharma, Biotest and Roche, outside the submitted work. Funding Information: The authors acknowledge the panel of experts who were involved and actively participated in the Delphi rounds to reach a consensus on the criteria to build the severity score: Elena Santagostino (Milan, Italy), Giancarlo Castaman (Florence, Italy), Alok Srivastava (Vellore, India), Angela Thomas (Edinburgh, UK), Karin Fijnvandraat (Amsterdam, the Netherlands), Patricia Casais (Buenos Aires, Argentina), Christoph Bidlingmaier (Munich, Germany), Carmen Escuriola-Ettinghausen (Frankfurt, Germany), Yesim Dargaud (Lyon, France), Gili Kenet (Tel hashomer, Israel), Paula James (Kingston, Canada), Johnny Mahlangu (Johannesburg, South Africa), Mike Makris (Sheffield, UK), Manuel Carcao (Toronto, Canada), Pia Petrini (Stockholm, Sweden), Rebecca Kruse-Jarres (Seattle, USA), Steve Kitchen (Sheffield, UK).
PY - 2018/10
Y1 - 2018/10
UR - http://www.scopus.com/inward/record.url?scp=85053270469&partnerID=8YFLogxK
U2 - 10.1111/jth.14257
DO - 10.1111/jth.14257
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 30182468
AN - SCOPUS:85053270469
SN - 1538-7933
VL - 16
SP - 2106
EP - 2110
JO - Journal of Thrombosis and Haemostasis
JF - Journal of Thrombosis and Haemostasis
IS - 10
ER -